Denali Therapeutics shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $47M | 2.5M | 19.20 |
| 2025-12-31 | $65M | 3.9M | 16.51 |
| 2025-09-30 | $66M | 4.6M | 14.52 |
| 2025-06-30 | $92M | 6.6M | 13.99 |
| 2025-03-31 | $59M | 4.4M | 13.60 |
| 2024-12-31 | $62M | 3.1M | 20.38 |
| 2024-09-30 | $84M | 2.9M | 29.13 |
| 2024-06-30 | $52M | 2.3M | 23.23 |
| 2024-03-31 | $33M | 1.6M | 20.52 |
| 2023-12-31 | $55M | 2.6M | 21.46 |
| 2023-09-30 | $60M | 2.9M | 20.63 |
| 2023-06-30 | $102M | 3.4M | 29.51 |
| 2023-03-31 | $82M | 3.5M | 23.04 |
| 2022-12-31 | $102M | 3.6M | 27.81 |
| 2022-03-31 | $158M | 4.9M | 32.17 |
| 2021-12-31 | $207M | 4.6M | 44.60 |
| 2021-09-30 | $240M | 4.8M | 50.45 |
| 2021-06-30 | $385M | 4.9M | 78.44 |
| 2021-03-31 | $346M | 6.1M | 57.10 |
| 2020-12-31 | $542M | 6.5M | 83.76 |
| 2020-09-30 | $156M | 4.4M | 35.83 |
| 2020-06-30 | $63M | 2.6M | 24.18 |
| 2020-03-31 | $21M | 1.2M | 17.51 |
| 2019-12-31 | $7.3M | 417k | 17.42 |
| 2019-09-30 | $6.7M | 440k | 15.32 |
| 2019-06-30 | $10M | 481k | 20.76 |
| 2019-03-31 | $11M | 481k | 23.22 |
| 2018-12-31 | $9.9M | 477k | 20.66 |
| 2018-09-30 | $10M | 476k | 21.74 |
| 2018-06-30 | $5.5M | 364k | 15.25 |
| 2018-03-31 | $7.3M | 372k | 19.69 |